-
1
-
-
0036191387
-
The physiology of lactoferrin
-
DOI 10.1139/o01-212
-
Brock JH (2002) The physiology of lactoferrin. Biochem Cell Biol 80:1-6 (Pubitemid 34194221)
-
(2002)
Biochemistry and Cell Biology
, vol.80
, Issue.1
, pp. 1-6
-
-
Brock, J.H.1
-
3
-
-
0032962172
-
Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: A pilot study
-
Tanaka K, Ikeda M, Nozaki A et al (1999) Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn J Cancer Res 90:367-371 (Pubitemid 29213539)
-
(1999)
Japanese Journal of Cancer Research
, vol.90
, Issue.4
, pp. 367-371
-
-
Tanaka, K.1
Ikeda, M.2
Nozaki, A.3
Kato, N.4
Tsuda, H.5
Saito, S.6
Sekihara, H.7
-
4
-
-
0036127867
-
Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b [7]
-
DOI 10.1016/S0002-9270(01)04135-1
-
Iwasa M, Kaito M, Ikoma J et al (2002) Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. Am J Gastroenterol 97:766-767 (Pubitemid 34245920)
-
(2002)
American Journal of Gastroenterology
, vol.97
, Issue.3
, pp. 766-767
-
-
Iwasa, M.1
Kaito, M.2
Ikoma, J.3
Takeo, M.4
Imoto, I.5
Adachi, Y.6
Yamauchi, K.7
Koizumi, R.8
Teraguchi, S.9
-
5
-
-
0036747346
-
Dose-response trial of lactoferrin in patients with chronic hepatitis C
-
Okada S, Tanaka K, Sato T et al (2002) Dose-response trial of lactoferrin in patients with chronic hepatitis C. Jpn J Cancer Res 93:1063-1069 (Pubitemid 35154274)
-
(2002)
Japanese Journal of Cancer Research
, vol.93
, Issue.9
, pp. 1063-1069
-
-
Okada, S.1
Tanaka, K.2
Sato, T.3
Ueno, H.4
Saito, S.5
Okusaka, T.6
Sato, K.7
Yamamoto, S.8
Kakizoe, T.9
-
6
-
-
33748151899
-
Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C
-
DOI 10.1016/j.hepres.2006.06.005, PII S1386634606002221
-
Konishi M, Iwasa M, Yamauchi K et al (2006) Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatol Res 36:27-32 (Pubitemid 44309286)
-
(2006)
Hepatology Research
, vol.36
, Issue.1
, pp. 27-32
-
-
Konishi, M.1
Iwasa, M.2
Yamauchi, K.3
Sugimoto, R.4
Fujita, N.5
Kobayashi, Y.6
Watanabe, S.7
Teraguchi, S.8
Adachi, Y.9
Kaito, M.10
-
7
-
-
0033869121
-
Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study
-
Yamauchi K, Hiruma M, Yamazaki N et al (2000) Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study. Mycoses 43:197-202
-
(2000)
Mycoses
, vol.43
, pp. 197-202
-
-
Yamauchi, K.1
Hiruma, M.2
Yamazaki, N.3
-
8
-
-
74049157768
-
Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial
-
Kozu T, Iinuma G, Ohashi Y et al (2009) Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res 2:975-983
-
(2009)
Cancer Prev Res
, vol.2
, pp. 975-983
-
-
Kozu, T.1
Iinuma, G.2
Ohashi, Y.3
-
9
-
-
0034906217
-
Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats
-
Kuwata H, Yamauchi K, Teraguchi S et al (2001) Functional fragments of ingested lactoferrin are resistant to proteolytic degradation in the gastrointestinal tract of adult rats. J Nutr 131:2121-2127 (Pubitemid 32720641)
-
(2001)
Journal of Nutrition
, vol.131
, Issue.8
, pp. 2121-2127
-
-
Kuwata, H.1
Yamauchi, K.2
Teraguchi, S.3
Ushida, Y.4
Shimokawa, Y.5
Toida, T.6
Hayasawa, H.7
-
10
-
-
0036089589
-
Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance
-
Togawa J, Nagase H, Tanaka K et al (2002) Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am J Physiol Gastrointest Liver Physiol 283:G187-G195 (Pubitemid 34666177)
-
(2002)
American Journal of Physiology - Gastrointestinal and Liver Physiology
, vol.283
, Issue.1
-
-
Togawa, J.-I.1
Nagase, H.2
Tanaka, K.3
Inamori, M.4
Umezawa, T.5
Nakajima, A.6
Naito, M.7
Sato, S.8
Saito, T.9
Sekihara, H.10
-
11
-
-
39149095568
-
Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in long-evans Cinnamon rats
-
Tsubota A, Yoshikawa T, Nariai K et al (2008) Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in long-evans Cinnamon rats. J Hepatol 48:486-493
-
(2008)
J Hepatol
, vol.48
, pp. 486-493
-
-
Tsubota, A.1
Yoshikawa, T.2
Nariai, K.3
-
12
-
-
65049084167
-
Lactoferrin is associated with a decrease in oocyte depletion in mice receiving cyclophosphamide
-
Horiuchi Y, Higuchi T, Tatsumi K et al (2009) Lactoferrin is associated with a decrease in oocyte depletion in mice receiving cyclophosphamide. Fertil Steril 91:2069-2078
-
(2009)
Fertil Steril
, vol.91
, pp. 2069-2078
-
-
Horiuchi, Y.1
Higuchi, T.2
Tatsumi, K.3
-
13
-
-
33745955355
-
Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine
-
DOI 10.1089/jir.2006.26.489
-
Kuhara T, Yamauchi K, Tamura Y et al (2006) Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J Interf Cytok Res 26:489-499 (Pubitemid 44061089)
-
(2006)
Journal of Interferon and Cytokine Research
, vol.26
, Issue.7
, pp. 489-499
-
-
Kuhara, T.1
Yamauchi, K.2
Tamura, Y.3
Okamura, H.4
-
14
-
-
0034434232
-
Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium
-
Kuhara T, Iigo M, Itoh T et al (2000) Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium. Nutr Cancer 38:192-199 (Pubitemid 32762019)
-
(2000)
Nutrition and Cancer
, vol.38
, Issue.2
, pp. 192-199
-
-
Kuhara, T.1
Iigo, M.2
Itoh, T.3
Ushida, Y.4
Sekine, K.5
Terada, N.6
Okamura, H.7
Tsuda, H.8
-
15
-
-
0030917254
-
Interleukin-11: Review of molecular, cell biology, and clinical use
-
Du X, Williams DA (1997) Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89:3897-3908 (Pubitemid 27220932)
-
(1997)
Blood
, vol.89
, Issue.11
, pp. 3897-3908
-
-
Du, X.1
Williams, D.A.2
-
16
-
-
0031298532
-
IL-11 Regulates Macrophage Effector Function Through the Inhibition of Nuclear Factor-κB
-
Trepicchio WL, Wang L, Bozza M et al (1997) IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J Immunol 159:5661-5670 (Pubitemid 127470321)
-
(1997)
Journal of Immunology
, vol.159
, Issue.11
, pp. 5661-5670
-
-
Trepicchio, W.L.1
Wang, L.2
Bozza, M.3
Dorner, A.J.4
-
17
-
-
0038297467
-
Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress
-
DOI 10.1016/S0016-5085(03)00282-8
-
Ropeleski MJ, Tang J, Walsh-Reitz MM et al (2003) Interleukin-11-induced heat shock protein 25 confers intestinal epithelialspecific cytoprotection from oxidant stress. Gastroenterology 124:1358-1368 (Pubitemid 36531810)
-
(2003)
Gastroenterology
, vol.124
, Issue.5
, pp. 1358-1368
-
-
Ropeleski, M.J.1
Tang, J.2
Walsh-Reitz, M.M.3
Musch, M.W.4
Chang, E.B.5
-
18
-
-
0037464753
-
Recombinant human interleukin 11 and bacterial infection in patients with haemological malignant disease undergoing chemotherapy: A double-blind placebo-controlled randomised trial
-
DOI 10.1016/S0140-6736(03)12322-7
-
Ellis M, Zwaan F, Hedström U et al (2003) Recombinant human interleukin 11 and bacterial infection in patients with haemological malignant disease undergoing chemotherapy: a doubleblind placebo-controlled randomized trial. Lancet 361:275-280 (Pubitemid 36126186)
-
(2003)
Lancet
, vol.361
, Issue.9354
, pp. 275-280
-
-
Ellis, M.1
Zwaan, F.2
Hedstrom, U.3
Poynton, C.4
Kristensen, J.5
Jumaa, P.6
Wassell, J.7
Al-Ramadi, B.8
-
19
-
-
0032989443
-
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease
-
DOI 10.1016/S0016-5085(99)70550-0
-
Sands BE, Bank S, Sninsky CA et al (1999) Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology 117:58-64 (Pubitemid 29297620)
-
(1999)
Gastroenterology
, vol.117
, Issue.1
, pp. 58-64
-
-
Sands, B.E.1
Bank, S.2
Sninsky, C.A.3
Robinson, M.4
Katz, S.5
Singleton, J.W.6
Miner Jr., P.B.7
Safdi, M.A.8
Galandiuk, S.9
Hanauer, S.B.10
Varilek, G.W.11
Buchman, A.L.12
Rodgers, V.D.13
Salzberg, B.14
Cai, B.15
Loewy, J.16
Debruin, M.F.17
Rogge, H.18
Shapiro, M.19
Schwertschlag, U.S.20
more..
-
20
-
-
0036186051
-
Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease
-
DOI 10.1046/j.1365-2036.2002.01179.x
-
Sands BE, Winston BD, Salzberg B et al (2002) Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease. Aliment Pharmacol Ther 16:399-406 (Pubitemid 34214518)
-
(2002)
Alimentary Pharmacology and Therapeutics
, vol.16
, Issue.3
, pp. 399-406
-
-
Sands, B.E.1
Winston, B.D.2
Salzberg, B.3
Safdi, M.4
Barish, C.5
Wruble, L.6
Wilkins, R.7
Shapiro, M.8
Schwertschlag, U.S.9
-
21
-
-
11144301728
-
A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy
-
DOI 10.1111/j.1572-0241.2004.40047.x
-
Lawitz EJ, Hepburn MJ, Casey TJ (2004) A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy. Am J Gastroenterol 99:2359-2364 (Pubitemid 40039366)
-
(2004)
American Journal of Gastroenterology
, vol.99
, Issue.12
, pp. 2359-2364
-
-
Lawitz, E.J.1
Hepburn, M.J.2
Casey, T.J.3
-
22
-
-
12344291865
-
Bone morphogenetic proteins
-
DOI 10.1080/08977190412331279890
-
Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233-241 (Pubitemid 40136452)
-
(2004)
Growth Factors
, vol.22
, Issue.4
, pp. 233-241
-
-
Chen, D.1
Zhao, M.2
Mundy, G.R.3
-
23
-
-
0346100581
-
Bone Morphogenetic Protein 2 Is Expressed by, and Acts Upon, Mature Epithelial Cells in the Colon
-
DOI 10.1053/j.gastro.2003.10.067
-
Hardwick JC, Van Den Brink GR, Bleuming SA et al (2004) Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 126:111-121 (Pubitemid 38040729)
-
(2004)
Gastroenterology
, vol.126
, Issue.SUPPL. 1
, pp. 111-121
-
-
Hardwick, J.C.H.1
Van Den Brink, G.R.2
Bleuming, S.A.3
Ballester, I.4
Van Den Brande, J.M.H.5
Keller, J.J.6
Offerhaus, G.J.A.7
Van Deventer, S.J.H.8
Peppelenbosch, M.P.9
-
24
-
-
34247882736
-
Transient expression of bone morphogenetic protein-2 in acute liver injury by carbon tetrachloride
-
Nakatsuka R, Taniguchi M, Hirata M et al (2007) Transient expression of bone morphogenetic protein-2 in acute liver injury by carbon tetrachloride. J Biochem 141:113-119
-
(2007)
J Biochem
, vol.141
, pp. 113-119
-
-
Nakatsuka, R.1
Taniguchi, M.2
Hirata, M.3
-
25
-
-
0034767215
-
Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide
-
DOI 10.1128/CDLI.8.6.1234-1239.2001
-
Yamaguchi M, Matsuura M, Kobayashi K et al (2001) Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide. Clin Diagn Lab Immunol 8:1234-1239 (Pubitemid 33035761)
-
(2001)
Clinical and Diagnostic Laboratory Immunology
, vol.8
, Issue.6
, pp. 1234-1239
-
-
Yamaguchi, M.1
Matsuura, M.2
Kobayashi, K.3
Sasaki, H.4
Yajima, T.5
Kuwata, T.6
-
26
-
-
66849091817
-
Oral bovine lactoferrin improves bone status of ovariectomizes mice
-
Blais A, Malet A, Mikogami T et al (2009) Oral bovine lactoferrin improves bone status of ovariectomizes mice. Am J Physiol Endocrinol Metab 296:E1281-E1288
-
(2009)
Am J Physiol Endocrinol Metab
, vol.296
-
-
Blais, A.1
Malet, A.2
Mikogami, T.3
-
27
-
-
0032833987
-
Myofibroblasts. II. Intestinal subepithelial myofibroblasts
-
Powell DW, Mifflin RC, Valentich JD et al (1999) Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277:C183-C201 (Pubitemid 29415032)
-
(1999)
American Journal of Physiology - Cell Physiology
, vol.277
, Issue.2
-
-
Powell, D.W.1
Mifflin, R.C.2
Valentich, J.D.3
Crowe, S.E.4
Saada, J.I.5
West, A.B.6
-
28
-
-
0028025037
-
Apical-to-basolateral transepithelial transport of human lactoferrin in the intestinal cell line HT-29 cl.19A
-
Mikogami T, Heyman M, Spik G et al (1994) Apical-to-basolateral transepithelial transport of human lactoferrin in the intestinal cell line HT-29 cl.19A. Am J Physiol 267:G308-G315
-
(1994)
Am J Physiol
, vol.267
-
-
Mikogami, T.1
Heyman, M.2
Spik, G.3
-
29
-
-
0033404492
-
Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions
-
Trepicchio WL, Ozawa M, Walters IB et al (1999) Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest 104:1527-1537 (Pubitemid 30002364)
-
(1999)
Journal of Clinical Investigation
, vol.104
, Issue.11
, pp. 1527-1537
-
-
Trepicchio, W.L.1
Ozawa, M.2
Walters, I.B.3
Kikuchi, T.4
Gilleaudeau, P.5
Bliss, J.L.6
Schwertschlag, U.7
Dorner, A.J.8
Krueger, J.G.9
-
30
-
-
70349914008
-
Bovine lactoferrin supplementation for prevention of late-onset sepsis in very lowbirth-weight neonates: A randomized trial
-
Manzoni P, Rinaldi M, Cattani S et al (2009) Bovine lactoferrin supplementation for prevention of late-onset sepsis in very lowbirth-weight neonates: a randomized trial. JAMA 302:1421-1428
-
(2009)
JAMA
, vol.302
, pp. 1421-1428
-
-
Manzoni, P.1
Rinaldi, M.2
Cattani, S.3
-
31
-
-
0029835760
-
Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats
-
Qiu BS, Pfeiffer CJ, Keith JC Jr (1996) Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig Dis Sci 41:1625-1630 (Pubitemid 26285750)
-
(1996)
Digestive Diseases and Sciences
, vol.41
, Issue.8
, pp. 1625-1630
-
-
Qiu, B.S.1
Pfeiffer, C.J.2
Keith Jr., J.C.3
-
32
-
-
0032742184
-
Interleukin-11 reduces T-cell-dependent experimental liver injury in mice
-
Bozza M, Bliss JL, Maylor R et al (1990) Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 30:1441-1447
-
(1990)
Hepatology
, vol.30
, pp. 1441-1447
-
-
Bozza, M.1
Bliss, J.L.2
Maylor, R.3
-
33
-
-
33744974556
-
Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells
-
DOI 10.1080/03008200600685350, PII V731630358282
-
Hori M, Sawai H, Tsuji Y et al (2006) Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells. Connect Tissue Res 47:124-132 (Pubitemid 43860233)
-
(2006)
Connective Tissue Research
, vol.47
, Issue.3
, pp. 124-132
-
-
Hori, M.1
Sawai, H.2
Tsuji, Y.3
Okamura, H.4
Koyama, K.5
|